4.7 Article

The Nitric Oxide (NO) Donor Molsidomine Counteract Social Withdrawal and Cognition Deficits Induced by Blockade of the NMDA Receptor in the Rat

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Procognitive activity of nitric oxide inhibitors and donors in animal models

Paulina Cieslik et al.

Summary: Nitric oxide plays important roles in neurological disorders such as Alzheimer's disease and mental disorders such as schizophrenia. This study investigated the effects of NO-related compounds on cognitive function in pharmacological models.

NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2022)

Article Clinical Neurology

Sodium nitroprusside enhances the antipsychotic-like effect of olanzapine but not clozapine in the conditioned avoidance response test in rats

Joep Titulaer et al.

Summary: The nitric oxide donor sodium nitroprusside has been shown to enhance the antipsychotic-like effect of olanzapine, but not clozapine, in rats. Rats also developed tolerance to clozapine after repeated administrations.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2022)

Article Psychiatry

Treatment-resistant schizophrenia-A RCT on the effectiveness of repeated-dose sodium nitroprusside

Marcelo P. M. Adelino et al.

Summary: This study evaluated the efficacy of repeated-dose SNP in treatment-resistant schizophrenia, and found that SNP was not efficacious in TRS, consistent with previous studies. The findings suggest that the efficacy of SNP may be limited to early stages of the disease.

SCHIZOPHRENIA RESEARCH (2021)

Review Chemistry, Medicinal

Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia

Giuseppe Caruso et al.

PHARMACEUTICALS (2020)

Article Clinical Neurology

Enhancement of the antipsychotic effect of risperidone by sodium nitroprusside in rats

Joep Titulaer et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2019)

Article Clinical Neurology

The role of striatum and prefrontal cortex in the prevention of amphetamine-induced schizophrenia-like effects mediated by nitric oxide compounds

Ana Carolina Issy et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)

Article Neurosciences

Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia

Ludmyla Kandratavicius et al.

BMC NEUROSCIENCE (2015)

Review Pharmacology & Pharmacy

The role of nitric oxide donors in schizophrenia: Basic studies and clinical applications

Nikolaos Pitsikas

EUROPEAN JOURNAL OF PHARMACOLOGY (2015)

Letter Pharmacology & Pharmacy

The Effects of Sodium Nitroprusside Treatment on Cognitive Deficits in Schizophrenia A Pilot Study

Joao Paulo Maia-de-Oliveira et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2015)

Article Neurosciences

Nitric Oxide and Schizophrenia: Present Knowledge and Emerging Concepts of Therapy

Hans-Gert Bernstein et al.

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2011)

Review Behavioral Sciences

Oxidative stress in schizophrenia: An integrated approach

Byron K. Y. Bitanihirwe et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2011)

Review Biochemistry & Molecular Biology

Targeting glutamate synapses in schizophrenia

Julie R. Field et al.

TRENDS IN MOLECULAR MEDICINE (2011)

Review Clinical Neurology

Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats

Larissa de Oliveira et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)

Review Pharmacology & Pharmacy

Review - Recent developments in nitric oxide donor drugs

M. R. Miller et al.

BRITISH JOURNAL OF PHARMACOLOGY (2007)

Article Pharmacology & Pharmacy

Memantine and recognition memory: Possible facilitation of its behavioral effects by the nitric oxide (NO) donor molsidomine

Nikolaos Pitsikas et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2007)

Review Behavioral Sciences

The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents

Ekrem Dere et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2007)

Article Neurosciences

Nitric oxide donor molsidomine attenuates psychotomimetic effects of the NMDA receptor antagonist MK-801

Nikolaos Pitsikas et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2006)

Review Medicine, General & Internal

Schizophrenia

R Freedman

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Article Neurosciences

Effects of ketamine in normal and schizophrenic volunteers

AC Lahti et al.

NEUROPSYCHOPHARMACOLOGY (2001)

Article Pharmacology & Pharmacy

Blockade of phencyclidine-induced effects by a nitric oxide donor

M Bujas-Bobanovic et al.

BRITISH JOURNAL OF PHARMACOLOGY (2000)